{
    "url_original": "https://www.wsj.com/articles/pfizer-asks-fda-to-approve-covid-19-vaccine-in-young-children-11633610319?mod=business_lead_pos1",
    "url": "pfizer-asks-fda-to-approve-covid-19-vaccine-in-young-children-11633610319",
    "title": "Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children",
    "sub_head": "5- to 11-year-olds may be able to start getting immunized by November, if health regulators authorize the shots",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-10-07 08:57:00",
    "body": "Pfizer Inc.  and  BioNTech SE  have asked U.S. health regulators to green light their Covid-19 vaccine for children 5 to 11 years old, setting up the shot to potentially be available to millions of youngsters in a matter of weeks.<br />The companies said Thursday that they submitted the application for authorization with the U.S. Food and Drug Administration."
}